Biogen shares soar on Alzheimer's drug developments By: FOX Business September 28, 2022 at 10:16 AM EDT A study found that Biogen's Alzheimer's drug lecanemab reduced cognitive and functional decline by 27% compared to a placebo over an 18-month period. Read More >>
